WO2008019710A1 - Vorrichtung zur stimulation mittels elektrischer und magnetischer felder sowie feld-applikatoren hierfür - Google Patents
Vorrichtung zur stimulation mittels elektrischer und magnetischer felder sowie feld-applikatoren hierfür Download PDFInfo
- Publication number
- WO2008019710A1 WO2008019710A1 PCT/EP2006/065839 EP2006065839W WO2008019710A1 WO 2008019710 A1 WO2008019710 A1 WO 2008019710A1 EP 2006065839 W EP2006065839 W EP 2006065839W WO 2008019710 A1 WO2008019710 A1 WO 2008019710A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- field
- frequency
- stimulation
- magnetic
- electric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
- A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
Definitions
- the invention relates to a device for stimulation by means of electric and magnetic fields and field applicators therefor.
- FIG. 1 shows the hitherto known main frequency ranges of physical stimulations.
- the amplitude spectrum derived from the earth magnetic field measurements by Fournier showed a resonance point at the Schumann or EEG ⁇ frequency 10 Hz. However, dominated were vibrations with the period of 4.5 seconds, which corresponds to a frequency of 0.22 Hz.
- the entire sympathetic [0.05 ... 0, 15 Hz] or parasympathetic [0, 16 ... 0.30 Hz] frequency range in the form of a pass through the externally impressed stimulation frequency in succession in an arbitrarily fine graduation (wobbled, swept).
- levels of these ranges 0.05; 0.06; 0.07; 0.08; 0.09; 0, 1; 0, 11; 0, 12; 0, 13; 0, 14, 0, 15 Hz and 0, 16, respectively; 0, 17; 0, 18; 0, 19; 0.20; 0.21; 0.22; 0.23; 0.24; 0.25; 0.26; 0.27; 0.28; 0.29 and 0.30 Hz.
- 30 seconds are sufficient as the respective stimulation time.
- the mean values of 0.1 Hz (sympathetic, blood pressure period, grape-herring oscillation) and 0.23 Hz (respiratory, parasympathetic) are impressed on the autonomic nervous system by about 4 minutes longer.
- the invention continues to be a continuous metrological detection of blood pressure or respiratory period and a constant comparison with the corresponding setpoints 0, 1 or 0.23 Hz.
- Based on control engineering process is by the stimulation of the nervous system with an alternating electric or magnetic energy an attempt is made to approximate the measured actual values to the optimum target values.
- This is realized according to the invention, as coupled with alternating fields that contain these frequencies or frequency ranges around 0, 1 and 0.23 Hz, the human autonomic nervous system is stimulating controllable.
- the FeId Applikatorsystem is designed for the upper body area, that sets a concentration of the magnetic flux in the upper body of the subject (central nervous system area). Also adapted to the physiological conditions in humans, the associated applicator system is realized for the lower half of the body so that the distribution of the field energy to both leg areas whose centers have a certain distance, and thus results in two field strength maxima.
- the electric field component is understood to mean an electric field generated between the head and foot regions.
- This E-field stimulates potential differences in contrast to the magnetic field.
- a field applicator according to the invention is equipped with a combination of a magnetic field generating coil assembly and an electric field generating electrode assembly.
- the electric field generating electrode can be designed simultaneously as a magnetic field generating coil.
- this control frequency is superimposed on selected frequencies of the EEG range as well as on m frequencies which produce biochemical reactions.
- an aggregation of erythrocytes occurring in the dark field of the blood is resolvable, above all, by frequencies in the range of approximately 250 to 1500 Hz.
- a Fourier series with the fundamental of about 250 Hz and the harmonics of about 500, 750, 1000, 1250, 1500,... Hz was determined as the optimum relationship if the amplitudes of these harmonics determine the relative proportions Vi, Y 3 , ⁇ k, 1/5, 1/6 ... and a total signal phase shift of 180 ° is realized.
- the signal thus generated is superimposed on the known frequencies of the EEG range and the corresponding control frequency of the autonomic nervous system. Since the erythrocytes, in particular their membrane, represent a vibration system and the optimal frequency (resonance frequency) is about 1 kHz, such an erythrocyte separation can be adjusted by resonance effect on the membrane. In the case of (pathological) erythrocyte aggregation, the flow properties of the blood deteriorate. Furthermore, due to an occurring damping, the resonance frequency of this system is reduced, as is known from the theory of (linear) systems. According to the invention, the possible frequency detuning of the blood cells is counteracted in that the frequency components contained in the signal are traversed in a defined bandwidth, that is to say oscillate to a small extent around a center frequency.
- the fields intended for the stimulation are generated via a special device for generating the fields.
- This device converts the electrical signals generated in the signal generating device into the energy forms intended for the stimulation.
- various devices in the form of simple electric coils, integrated in a mat applicator known.
- various electric coils are arranged so that they use a predominantly magnetic field-induced field for application. Since the operation of the device takes place at frequencies below 1 MHz, almost no electric fields are generated by the known device.
- the balance of electric and magnetic fields known from electromagnetics only sets in at a distance far above the wavelength, which is still about 300 m even at a frequency of IMHz. Accordingly, in the immediate field of application of the device, the known devices produce virtually no electrical field component.
- stimulation is particularly effective in the combination of electric and magnetic fields.
- Figure 2 shows a simple device for generating an electric field combined with a magnetic field by converting electrical signals, the electric field following the magnetic field
- FIG. 3 shows an expanded circuit of the device for generating an electric field combined with a magnetic field, wherein the electric field can be controlled independently of the magnetic field,
- FIG. 4 shows an expanded device for generating an electric field combined with a magnetic field
- FIG. 5 shows a special embodiment of the device for generating an electric field combined with a magnetic field
- FIG. 6 shows the distribution of the electric field between the upper and the lower coil in an arrangement according to FIG. 3
- 7 shows the distribution of the electric field between a voltage electrode and a coil system in an arrangement according to FIG. 4 or 5
- FIG. 6 shows the distribution of the electric field between the upper and the lower coil in an arrangement according to FIG. 3
- 7 shows the distribution of the electric field between a voltage electrode and a coil system in an arrangement according to FIG. 4 or 5
- FIG. 6 shows the distribution of the electric field between the upper and the lower coil in an arrangement according to FIG. 3
- 7 shows the distribution of the electric field between a voltage electrode and a coil system in an arrangement according to FIG. 4 or 5
- FIG. 6 shows the distribution of the electric field between the upper and the lower coil in an arrangement according to FIG. 3
- 7 shows the distribution of the electric field between a voltage electrode and a coil system in an arrangement according to FIG. 4 or 5
- FIG. 6 shows the distribution of the electric field between the upper and the lower coil in an arrangement according to FIG. 3
- FIG. 8 the course of the magnetic flux density over a coil arrangement adapted to the physiological conditions
- FIG. 9 shows an embodiment of the device for generating an electric field combined with a magnetic field based on the embodiment according to FIG. 5, FIG.
- FIG. 10 shows a simple device for checking the functioning of the device for test subject stimulation by means of special electric and magnetic fields and optimized field applicators
- FIG. 11 shows the characteristic course of peripheral perfusion parameters, derived with the noninvasive NIRP method from the measurement site of the fingerstick in a 40-year normal subject, when changing the E-field component of a stimulation program "Vitality" as an exemplary embodiment
- FIG. 12 shows an oscillation period of the low-frequency sympathetic (a) and parasympathetic (b) control frequency as the base oscillation of a corresponding stimulation program
- FIG. 13 shows the periodic course of the defined higher-frequency IIS function i IIS (t) [iis ... ion injection signal] with the period of 4 ms ⁇ 250 Hz and the frequencies 250, 500, 750, 1000 and 1250 Hz, if the respective amplitudes of these vibrations have the relative proportions 1, Vi, Y 3 , VA 1 1/5, 1/6,
- FIG. 14 shows as a generalized embodiment a result of blood-darkfield recordings made in a 55-year-old diabetic patient before, after 2, 4 and 12 minutes of stimulation with the IIS function i IIS (t) according to FIG.
- FIG. 15 shows characteristic oscillation frequencies which are superimposed on the parasympathetic control frequency of 0.25 Hz for a stimulation program "Relax" as exemplary embodiment: a) Basic oscillation 0.25 Hz with a relative amplitude of 50% and a relax reference frequency (EEG Delta) Frequency) of 2 Hz at 100% amplitude, b) EEG alpha frequency of 10 Hz with 50% and 100 Hz with 40% to the reference signal (reference frequency) of 2 Hz, c) total signal from addition of a) and b) as well of i IIS (t) [see Figure 13] for the stimulation time of 4 s, which corresponds to the period of the base oscillation of 0.25 Hz ⁇ 4 s,
- FIG. 16 shows characteristic oscillation frequencies which are superimposed on the parasympathetic control frequency of 0.25 Hz for a stimulation program "Vitality" as exemplary embodiment: a) Vitality reference frequency of 10 Hz (EEG alpha frequency) with 100% amplitude component and 100 Hz with 40% amplitude component, b) total signal from addition of a) as well as 0.25 Hz (50% amplitude component, see Figure 12) and of i IIS (t) [see Figure 13] for the stimulation time of 4 s, the Period of the base oscillation of 0.25 Hz ⁇ 4 s, and
- FIG. 17 shows characteristic oscillation frequencies which are superimposed on the sympathetic control frequency of 0.1 Hz for a stimulation program "Performance" as exemplary embodiment: a) Performance reference frequency of 10 Hz (EEG alpha frequency) at 100% amplitude component and 20 Hz at 70 ° % Amplitude and 100 Hz with
- the apparatus of Figure 2 is characterized in that the applicator of two coil systems 20 and 30 is constructed, which are spatially arranged so that on the one hand, a concentration of Magnetic fields to different areas of the impact is achieved, on the other hand, but also a potential difference between the coils leads to the establishment of a specific electric field.
- the potential difference is generated by the voltage drop across a resistor 40 connected between terminal 22 and terminal 31.
- This wiring ensures that the electric field follows the magnetic field. If a direct current (DC component) is superimposed on the current for generating the magnetic field, the formation of a constant E field is additionally achieved.
- DC component direct current
- two coil systems 20 and 30 with the terminals 21 and 22 for the coil system 20 and the terminals 31 and 32 for the coil system 30.
- a current 51 is fed into the coil systems such that the current first Coil 20 flows through, then via a resistor 40 which is connected between the terminals 22 and 31, is conducted into the coil system 30 and then flows back via the terminal 32 to the power source.
- the effect of the electric field is created by the voltage drop across the resistor, so that between the coil system 20 and 30, an electrical potential difference is built up.
- the current flow in the coil systems in turn generates the effect of the magnetic field.
- the current 51 is modulated by the current source 50 in the intensity with the frequencies described above, so that the electric and magnetic fields in the manner described can exert their effect.
- FIG. 3 shows an extension of the functional ity of the example of Figure 2 by a modified circuit.
- FIG. 3 shows in detail: Two coil systems 20 and 30 with the connections 21 and 22 for the system 20 and 31 and 32 for the system 30.
- the current sources 50 generate a current modulated according to the target position into the one coil system shown here System 30, fed.
- the current source 51 also feeds a current into the system 20 and generates in the area of action of this coil system a second magnetic field, which can also be controlled by the separate current source independently in intensity or frequency composition of that of the first coil system.
- an electrical potential difference is generated with a voltage source 60, so that an electric field can form between the two coil systems.
- This mat applicator arrangement has two advantages. On the one hand, one is largely free in the design of the magnetic field generating coil system and can be based on the optimal application target position.
- the electric field can be optimized in the same way, so that both fields can be pronounced independently of each other.
- Another advantage over the arrangements according to FIGS. 2 and 3 is the concentration of the electric field on the one side of the applicator from which the application originates. The rear side of the same shields the electric field, so that on the one hand no interference can occur, for example, by electrical lines below the mat applicator.
- Figure 4 shows a coil system 20 with the terminals 21 and 22, which can be constructed in a simple manner in a plane which is embedded for example in a mat.
- an electrode 30 is arranged, which can be closed in area or covered by individual conductive paths covering a surface.
- the magnetic field controlling current source 51 feeds the controlling current into the terminals 21 and 22.
- the electric field controlling voltage source 60 generates a controlled potential between the electrode 30 and the coil system 20.
- Figure 5 shows a specific embodiment of the device for generating an electric field combined with a magnetic field, wherein the coil system is designed so that a field distribution adapted to the physiology of the animal, which may be both a human and an animal, arises.
- Figure 5 shows the coil system between the terminal 21 and 22 consisting of the sub-coils 201 and 202 and 203. Furthermore, an electrode 30 is shown for the electric field.
- the arrangement of the coils 201 and 202 is made such that the current flows through them in the opposite direction. That is, the magnetic field is concentrated in the middle, as can be seen from the diagram of the field strength distribution in FIG. 8, section A-A.
- the arrangement of the coil 203 is made such that the strong magnetic field formation over the lateral coil conductors optimally comes into effect under the extremities, as the diagram of the field strength distribution in FIG. 8 shows section B-B.
- the effect of the voltage electrode is shown in FIG. 7 as a field line diagram in section C-C.
- FIG. 3 Shown are the field lines, which form between a positive potential, for example, of the coil 20 and a correspondingly negative potential of the coil 30. Evident is the symmetrical training up and down.
- FIG. 7 shows the field lines of an electric field which is established between an example positive electrode and the correspondingly negative coil system.
- the lines each connect the positive, bright side to the negative, dark side of the potential.
- FIG. 8 shows the course of the magnetic flux density over a coil arrangement adapted to the given physiological conditions, the diagram of the solid line showing the course in the region of the section BB (see FIG. 5) and the broken line the course in the region of the section AA (FIG. see Figure 5). Visible is the concentration of the field strength in the section A-A on the central region, which is preferably arranged in the region of the spine, and the distribution of the field strength maxima on two sides, so that this arrangement is preferred for the extremities.
- Figure 9 shows an embodiment of the device for generating an electric field combined with a magnetic field based on the embodiment of Figure 5, wherein the coils 201, 202 and 203 only consist of a flat, flat current loop.
- These flat, parallel current paths can be integrated, for example, in a mat applicator by the interconnects are incorporated by electrically conductive yarns in weft and / or chain.
- the interconnects are connected in such a way that a coil system adapted to the given physiological conditions arises, wherein each of the coils of the system consists of only a single current loop.
- the current for generating the magnetic field is introduced by the current source I in the terminal b. After the current flows through the coils 202 and 201, it is forwarded to the coil 203 in the lower region and then fed via the terminal c to the power source again. With the voltage source U is between the electrode 30 and the coil system 201, 202, 203 generates an electric field by connecting the voltage via the terminal a to the electrode 30 and via the terminal c to the coil system.
- connection cable with the conductors a, b and c is designed so that the current-carrying lines a and b are twisted and the line c as a shield over the lines a and b is drawn.
- the arrangement of the coils is preferably carried out in such a way that the coils 201 and 202 obtains their effect in the region of the spine of a human or possibly a vertebrate and the coil 203 reaches its effect in the region of the extremities, in particular of the legs.
- the distance between the upper and lower coils can be made variable.
- the spacing of the longitudinal current paths in the coil 203 is to be adapted to the distance of the legs, so that the maxima of the magnetic flux density recognizable in FIG. 8, section B-B, can optimally stimulate the nerve tracts as well as the peripheral blood vessels in the limbs.
- Figure 10 shows a simple device for checking the operation of the device for generating a combined electric and magnetic field with the underlying frequencies for the desired effect.
- This device includes a coil 100 that forms, with the capacitor 200, a resonant circuit that is responsive to a characteristic frequency of the signal mix of the i IIS signal, e.g. B. 1000 Hz, is tuned and thus not detected 50 Hz noise and other signals.
- the detector 300 in the simplest case a diode, generates from the alternating voltage induced in the oscillating circuit by the stimulus signal a control signal which is possibly amplified by the amplifier 400.
- the control signal is indicated by means of an indicator 500, which in the simplest case may be a light-emitting diode, but which may also have several display states.
- a generalized device realized in such a way that in addition to the device for checking the operation of the device for generating a combined electric and magnetic field with the underlying basis for the intended effect frequencies and in parallel via a separate system coil / Resonance circuit, the detection of 50 or 60 Hz - interference is possible.
- FIG. 12 shows a period of oscillation of the low-frequency sympathetic (a) and parasympathetic (b) control frequency as the base oscillation of a corresponding stimulation program.
- the sympathetic (0, 1 Hz ⁇ 10 s oscillation period) and parasympathetic (0.25 Hz ⁇ 4 s oscillation period) base oscillation are superimposed corresponding higher-frequency oscillations, as shown in Figures 13 and 15 to 17.
- the IIS function i IIS (t) according to FIG. 13 is superimposed on the stimulation programs, specifically the control frequencies 0, 1 and 0.25 Hz as well as corresponding EEG frequencies and the frequency 100 Hz in order to dissolve and improve especially occurring (pathological) erythrocyte aggregations To achieve blood flow properties.
- FIG. 14 shows how the erythrocytes separate under stimulation with the IIS function i IIS (t) according to FIG. 13, after apparent pathological erythrocyte aggregation before the stimulation templates. It has been recognized according to the invention that, in the case of a stimulation, initially only such an IIS signal is to act for approximately 4 minutes, then the stimulation application program is to be activated (see Figures 15 to 17).
- the frequency of 2 Hz represents a typical EEG-delta frequency for the stimulation program "Relax” and highly significant changes in insomnia occur at such delta frequencies
- the lOHz fields also highly significant results, inter alia, in immunobiological reactions, edema inhibition, weather sensitivity, improving the ability to concentrate, general performance improvement before.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Magnetic Treatment Devices (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE502006008259T DE502006008259D1 (de) | 2006-08-17 | 2006-08-31 | Vorrichtung zur stimulation mittels elektrischer und magnetischer felder sowie feld-applikatoren hierfür |
US12/303,389 US8750984B2 (en) | 2006-08-17 | 2006-08-31 | Device for stimulation by means of electric and magnetic fields, and field applicators for this purpose |
EP06793083A EP2051773B1 (de) | 2006-08-17 | 2006-08-31 | Vorrichtung zur stimulation mittels elektrischer und magnetischer felder sowie feld-applikatoren hierfür |
AT06793083T ATE486629T1 (de) | 2006-08-17 | 2006-08-31 | Vorrichtung zur stimulation mittels elektrischer und magnetischer felder sowie feld-applikatoren hierfür |
AU2006347229A AU2006347229B2 (en) | 2006-08-17 | 2006-08-31 | Device for stimulation by means of electric and magnetic fields, and field applicators for this purpose |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EPPCT/EP2006/065404 | 2006-08-17 | ||
EPPCT/EP2006/065404 | 2006-08-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008019710A1 true WO2008019710A1 (de) | 2008-02-21 |
Family
ID=37882542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/065839 WO2008019710A1 (de) | 2006-08-17 | 2006-08-31 | Vorrichtung zur stimulation mittels elektrischer und magnetischer felder sowie feld-applikatoren hierfür |
Country Status (6)
Country | Link |
---|---|
US (1) | US8750984B2 (de) |
EP (1) | EP2051773B1 (de) |
AT (1) | ATE486629T1 (de) |
AU (1) | AU2006347229B2 (de) |
DE (1) | DE502006008259D1 (de) |
WO (1) | WO2008019710A1 (de) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102010038249A1 (de) | 2010-10-18 | 2012-04-19 | Manexco-Consult Ag | Verfahren und Vorrichtung zur physikalischen Stimulation von menschlichem Gewebe |
WO2019164903A1 (en) * | 2018-02-20 | 2019-08-29 | University Of Iowa Research Foundation | Therapeutic systems using magnetic and electric fields |
US11850440B2 (en) | 2019-08-22 | 2023-12-26 | University Of Iowa Research Foundation | Therapeutic systems using magnetic fields |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11191975B2 (en) * | 2009-07-14 | 2021-12-07 | Pulse, Llc | Micro-coil wristband |
US11878181B2 (en) | 2009-07-14 | 2024-01-23 | Pulse, Llc | Micro-coil wristband |
ITFO20130007A1 (it) * | 2013-11-05 | 2015-05-06 | Egidio Tullio | Dispositivo elettrico e/o elettronico e procedimento di generazione di un fenomeno fisico variabile nel tempo. |
DE102017123854B4 (de) * | 2017-10-13 | 2020-12-17 | Prof. Dr. Fischer AG | Magnetfeldapplikator zur Magnetstimulation von Körpergewebe mit körperlich wahrnehmbarer Rückmeldung |
US20230149729A1 (en) * | 2020-04-03 | 2023-05-18 | Regents Of The University Of Minnesota | Spintronic nanodevice for low-power, cellular-level, magnetic neurostimulation |
CN112362726A (zh) * | 2020-10-09 | 2021-02-12 | 郑州大学 | 一种基于磁性颗粒检测建筑材料内部缺陷的装置及方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4889526A (en) * | 1984-08-27 | 1989-12-26 | Magtech Laboratories, Inc. | Non-invasive method and apparatus for modulating brain signals through an external magnetic or electric field to reduce pain |
US5156587A (en) * | 1983-09-01 | 1992-10-20 | Montone Liber J | Method for treating malignant cells |
US5899922A (en) * | 1993-05-28 | 1999-05-04 | Loos; Hendricus G. | Manipulation of nervous systems by electric fields |
US6675047B1 (en) * | 1999-06-28 | 2004-01-06 | Sergei Petrovich Konoplev | Electromagnetic-field therapy method and device |
DE102004024655A1 (de) * | 2003-06-06 | 2005-01-05 | Software + Systeme Erfurt Gmbh | Arbeitsverfahren zum Betreiben einer Vorrichtung zur Probanden-Stimulation mittels zeitveränderlicher Mikroströme und/oder Magnetfelder und/oder Licht sowie zugehörige Vorrichtung |
US20050080459A1 (en) * | 2003-10-09 | 2005-04-14 | Jacobson Jerry I. | Cardioelectromagnetic treatment |
-
2006
- 2006-08-31 WO PCT/EP2006/065839 patent/WO2008019710A1/de active Application Filing
- 2006-08-31 AU AU2006347229A patent/AU2006347229B2/en not_active Ceased
- 2006-08-31 EP EP06793083A patent/EP2051773B1/de not_active Not-in-force
- 2006-08-31 AT AT06793083T patent/ATE486629T1/de active
- 2006-08-31 US US12/303,389 patent/US8750984B2/en not_active Expired - Fee Related
- 2006-08-31 DE DE502006008259T patent/DE502006008259D1/de active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5156587A (en) * | 1983-09-01 | 1992-10-20 | Montone Liber J | Method for treating malignant cells |
US4889526A (en) * | 1984-08-27 | 1989-12-26 | Magtech Laboratories, Inc. | Non-invasive method and apparatus for modulating brain signals through an external magnetic or electric field to reduce pain |
US5899922A (en) * | 1993-05-28 | 1999-05-04 | Loos; Hendricus G. | Manipulation of nervous systems by electric fields |
US6675047B1 (en) * | 1999-06-28 | 2004-01-06 | Sergei Petrovich Konoplev | Electromagnetic-field therapy method and device |
DE102004024655A1 (de) * | 2003-06-06 | 2005-01-05 | Software + Systeme Erfurt Gmbh | Arbeitsverfahren zum Betreiben einer Vorrichtung zur Probanden-Stimulation mittels zeitveränderlicher Mikroströme und/oder Magnetfelder und/oder Licht sowie zugehörige Vorrichtung |
US20050080459A1 (en) * | 2003-10-09 | 2005-04-14 | Jacobson Jerry I. | Cardioelectromagnetic treatment |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102010038249A1 (de) | 2010-10-18 | 2012-04-19 | Manexco-Consult Ag | Verfahren und Vorrichtung zur physikalischen Stimulation von menschlichem Gewebe |
WO2019164903A1 (en) * | 2018-02-20 | 2019-08-29 | University Of Iowa Research Foundation | Therapeutic systems using magnetic and electric fields |
US11071875B2 (en) | 2018-02-20 | 2021-07-27 | University Of Iowa Research Foundation | Therapeutic systems using magnetic and electric fields |
US11980768B2 (en) | 2018-02-20 | 2024-05-14 | University Of Iowa Research Foundation | Therapeutic systems using magnetic and electric fields |
US11850440B2 (en) | 2019-08-22 | 2023-12-26 | University Of Iowa Research Foundation | Therapeutic systems using magnetic fields |
Also Published As
Publication number | Publication date |
---|---|
AU2006347229B2 (en) | 2010-12-09 |
DE502006008259D1 (de) | 2010-12-16 |
US8750984B2 (en) | 2014-06-10 |
EP2051773A1 (de) | 2009-04-29 |
EP2051773B1 (de) | 2010-11-03 |
US20090248098A1 (en) | 2009-10-01 |
ATE486629T1 (de) | 2010-11-15 |
AU2006347229A1 (en) | 2008-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2051773B1 (de) | Vorrichtung zur stimulation mittels elektrischer und magnetischer felder sowie feld-applikatoren hierfür | |
EP3513836B1 (de) | Magnetfeldapplikator mit einem rampenförmigen signalverlauf der verwendeten spulenströme | |
AT163979B (de) | Elektromedizinischer Apparat | |
DE2545675C2 (de) | Interferenzstromtherapiegerät | |
EP0612259B1 (de) | Elektrotherapie-gerät | |
DE2314573C2 (de) | Gerät zur Förderung von Heilungsprozessen | |
DE2745349C2 (de) | Interferenzstromtherapiegerät | |
DE102017108084B4 (de) | Pulsquelle und Verfahren für die magnetisch induktive Nervenreizung | |
DE2322953A1 (de) | Reizstromgeraet | |
WO1994005370A1 (de) | Elektrotherapeutisches gerät | |
DE10237519A1 (de) | Magnetfeldtherapie | |
DE10157024B4 (de) | Vorrichtung zur Erzeugung von pulsierenden elektromagnetischen und/oder elektrischen Feldern | |
DD276778A3 (de) | Reizstromgeraet zur elektrischen stimulation von muskeln | |
WO1999059674A1 (de) | Magnetstimulationsgerät | |
DE2052994C2 (de) | Reizstromtherapiegerät | |
DE102008039387B4 (de) | Vorrichtung zur transkutanen Stimulation | |
DE2736345C2 (de) | Gerät zur Erzeugung eines elektrischen Behandlungsstromes im Zellgewebe eines Patienten | |
DE3335018A1 (de) | Verfahren zur steuerung eines pulsierenden magnetfeldes und vorrichtung zur durchfuehrung des verfahrens | |
DE102004024655B4 (de) | Vorrichtung zur Probanden-Stimulation mittels zeitveränderlicher Mikroströme | |
DE102009061154B3 (de) | Vorrichtung zur Erzeugung eines magnetischen Signals | |
DE102009017229B4 (de) | Vorrichtung und Verfahren zur Erzeugung eines magnetischen Signals | |
DE102007012474B4 (de) | Elektrotherapiegerät | |
DE1805284A1 (de) | Verfahren zur Aufbereitung von Schwingungstraegern als Mittel fuer die Erkennung und Behandlung von Krankheiten | |
DE10054477A1 (de) | Mangetfeldtherapievorrichtung und Verfahren | |
WO2023187492A1 (de) | Vorrichtung zur aurikulären punktualstimulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06793083 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006793083 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006347229 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2006347229 Country of ref document: AU Date of ref document: 20060831 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2006347229 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12303389 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |